Meta‐analyses clearly show that the lncRNA NEAT1 is upregulated in various cancer entities resulting in an unfavorable prognosis as well as a poor overall survival and, thus, these studies conclude that NEAT1 could be a suitable prognostic biomarker candidate for clinicopathological features in cancer pathology (Chen et al., 2017b; Yang et al., 2017a; Zhang et al., 2017c). Here, NEAT1 is linked to cancer.